Thank you for your letter of 21 February. It was good you explained your position clearly; it wasn't boring at all.

I welcomed your openness to the suggestion that it might be wise to think though the implications of direct-to-consumer advertising before taking things further. I also think that the case for a moratorium is underlined by the fact that we are both strongly committed to the same basic objective - much better patient information - yet disagree about the risks of DTCA (and I suspect on the quality of much prescribing too).

I agree that we should now put this correspondence to bed but, if Patients Association does go on to develop a formal policy on DTCA, I do hope Mike Stone will let me have a copy in due course.

	Contents page
	What's New?